Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
2.4K Views
•
06:44 min
•
March 29th, 2021
DOI :
March 29th, 2021
•Charles A. Havnar1, Oliver Zill2, Jeff Eastham1, Jeffrey Hung1, Manana Javey3, Emmanuel Naouri3, Jennifer Giltnane1, Justin M. Balko4, Andrew Wallace2, Nicolas Lounsbury2, Daniel Oreper2, Sarajane Saturnio1, G-Y Yang5, Amy A. Lo1
1Departments of Research Pathology, Genentech, 2Bioinformatics & Computational Biology, Genentech, 3Roche Sequencing Solutions, Hacienda Drive, 4Department of Medicine, Vanderbilt University Medical Center, Medical Center Drive, 5Department of Pathology, Northwestern University, Feinberg School of Medicine
Explore More Videos
Chapters in this video
0:05
Introduction
0:43
Automated Tissue Dissection
5:23
Results: Confirmation of the Automated Dissection
6:19
Conclusion
Related Videos
08:32
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
9.5K Views
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
6.7K Views
13:01
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
3.5K Views
07:29
A Simple and Rapid Protocol to Non-enzymatically Dissociate Fresh Human Tissues for the Analysis of Infiltrating Lymphocytes
19.9K Views
03:49
Optimized Nuclei Isolation from Fresh and Frozen Solid Tumor Specimens for Multiome Sequencing
933 Views
07:34
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
585 Views
05:58
Dissociation of Human and Mouse Tumor Tissue Samples for Single-cell RNA Sequencing
2.5K Views
06:06
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
408 Views
07:10
Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells
12.6K Views
Isolation of Immune Cells from Primary Tumors
37.4K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved